Neobe selected to present at the first Cambridge x London Life Sciences Showcase during JP Morgan week
Pedro Correa de Sampaio presenting at the Cambridge x London Life Sciences Showcase
Neobe, a preclinical startup engineering first in class microbial vectors to unlock curative responses in cancer patients, recently presented at the inaugural Cambridge x London Life Sciences Showcase, hosted by the o2h Group, during JPM Healthcare Week 2026 in San Francisco.
Our co-founder and CEO Pedro Correa de Sampaio participated in a series of meetings and discussions with investors and industry partners highlighting our collaborative vision and ongoing work towards transforming cancer treatment through precision stromal remodelling.
Neobe Therapeutics’ successful participation outlines its continued momentum towards building strategic partnerships as it advances its mission to address the major unsolved challenge in oncology that is ineffective drug treatments in solid tumours.
Latest news
